FIZE Medical has raised $20.0M in Series B funding to expand its real-time renal monitoring technology. The round was led by Rapha Capital Management and Asahi Kasei Medical.
The company's platform tracks renal output continuously, giving clinicians in operating rooms and critical care units a live read on a vital sign that's typically checked intermittently. That kind of monitoring can help providers catch complications earlier and reduce hospitalization-related risks.






.png&w=3840&q=75)










